drugset / Trial / NCT05856578

Comparing the Efficacy of Mulberry Twig Alkaloid Tablet and Canagliflozin in Patients With Type 2 Diabetes

NCT05856578

RandomizedParallel-groupSingle-blindTreatment

Summary

The aim of the study is to investigate the efficacy and safety of Mulberry Twig (Ramulus Mori, Sangzhi) Alkaloid Tablet and Canagliflozin for 12 weeks in individuals with type 2 diabetes mellitus

Timeline

Start
2022-03-15
Primary completion
2023-05-31
Completion
2023-12-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator CANAGLIFLOZIN ANHYDROUS Small molecule 100 mg Oral
Subject Mulberry Twig (Ramulus Mori, Sangzhi) Alkaloid Tablet 50mg po tid Unknown 50 mg Oral